Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Urgent action needed to tackle disposal of antibiotics - UN
Once consumed, most antibiotic drugs are excreted un-metabolised, along with resistant bacteria, through urine and faeces.
Study finds release of drugs into the environment is driving AMR

‘Careless’ disposal of antibiotics could lead to the emergence of ‘ferocious superbugs’ by driving antimicrobial resistance, according to United Nations (UN) experts.

Previous research has linked AMR to the misuse of antibiotics in humans and agriculture, but little attention has been given to the role of the environment and pollution.

This year’s Frontiers Report, released at the UN Environment Assembly in Nairobi, suggests the emergence and spread of AMR is being driven by antimicrobial compounds from homes, hospitals, pharmaceutical facilities and agricultural run-off being released into the environment; as well as direct contact between national bacterial communities and discharged resistant bacteria.

Once consumed, most antibiotic drugs are excreted un-metabolised, along with resistant bacteria, through urine and faeces, the report says.

Evidence also shows multi-drug resistant bacteria is prevalent in marine waters and sediments close to aquaculture, industry and municipal discharges.

“The warning here is truly frightening,” said Erik Solheim, chief of the UN Environment Programme. “We could be spurring the development of ferocious superbugs through ignorance and carelessness.”

Around 700,000 people die of resistant infections every year across the globe.

Mr Solheim continued: “This needs priority action right now, or else we run the risk of allowing resistance to occur through the back door, with potentially terrifying consequences.”

Solving the issue, according to the report, will involve tackling the use and disposal of antibiotics, as well as the release of antimicrobial drugs, contaminants and resistant bacteria into the environment.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.